Nursing Care and Interventions in Managing Chronic Renal

  • Slides: 32
Download presentation
Nursing Care and Interventions in Managing Chronic Renal Failure Keith Rischer RN, MA, CEN

Nursing Care and Interventions in Managing Chronic Renal Failure Keith Rischer RN, MA, CEN 1

Todays Objectives… Ø Ø Ø Review the pathophysiology and causes of chronic renal failure

Todays Objectives… Ø Ø Ø Review the pathophysiology and causes of chronic renal failure (CRF). Contrast lab findings and physiologic changes associated with acute vs. chronic renal failure. Identify relevant nursing diagnosis statements and prioritize nursing care for clients with CRF including dietary modifications. Compare and contrast the following treatment modalities: peritoneal dialysis, hemodialysis, and continuous renal replacement therapies. Identify nursing care priorities with hemodialysis and peritoneal dialysis. Prioritize teaching needs of clients with CRF. 2

3

3

Patho 4

Patho 4

Patho: Chronic Renal Failure Ø Progressive, irreversible kidney injury Kidney function does not recover

Patho: Chronic Renal Failure Ø Progressive, irreversible kidney injury Kidney function does not recover q Azotemia q Increase nitrogenous wastes such as BUN ü Creatinine ü q Uremia ü ü q azotemia with symptoms (chart 75 -5 p. 1739) Anorexia, N&V, fatigue, SOB Uremic syndrome (urine in the blood) Altered fluid, lyte and acid-base balance ü clinical and lab manifestations of renal failure ü More severe weakness, lethargy, confusion…coma. . death ü 5

Patho: Stages of Chronic Renal Failure Ø Diminished renal reserve q GFR ½ normal

Patho: Stages of Chronic Renal Failure Ø Diminished renal reserve q GFR ½ normal q Compensation w/healthy nephrons Ø Renal insufficiency q Nephrons destroyed…remaining adapt q BUN, creatinine, uric acid elevate q Priorities: fluid volume, diet, control of HTN, Ø End-stage renal disease q Severe fluid, acid-base imbalances q Dialysis needed or will die 6

Patho: Physiologic Changes • • • Kidney • Decreased GFR • Poor H 2

Patho: Physiologic Changes • • • Kidney • Decreased GFR • Poor H 2 O excretion Metabolic – BUN and creatinine increased Electrolytes – Sodium- later stages sodium retention – Potassium increased – EKG changes – Kayexelate • • Acid-base balance: metabolic acidosis Calcium decreased and phosphorus increased 7

Patho: Physiologic Changes • • • Cardiac – Hypertension – Hyperlipidemia – Congestive heart

Patho: Physiologic Changes • • • Cardiac – Hypertension – Hyperlipidemia – Congestive heart failure – Uremic pericarditis Hematologic • anemia Gastrointestinal • • • Halitosis Stomatitis PUD 8

Patho: Physiologic Changes Ø Neurologic q q Ø Respiratory q q Ø pulmonary effusion

Patho: Physiologic Changes Ø Neurologic q q Ø Respiratory q q Ø pulmonary effusion SOB Urinary q Ø lethargy Uremic encephalopathy proteinuria, oliguria, dilute Skin q dry, pallor, pruritus, ecchymosis 9

Drug Therapy Ø Ø Ø Ø chart 75 -3 p. 1737 Cardioglycides q Digoxin/Lanoxin

Drug Therapy Ø Ø Ø Ø chart 75 -3 p. 1737 Cardioglycides q Digoxin/Lanoxin Calcium channel blockers Diuretics Vitamins and minerals q Folic Acid q Ferrous Sulfate Biologic response modifiers q Erthropoetin (Epogen) Phosphate binders q Aluminum hydroxide Stool softeners and laxatives 10

Patho of One Dialysis/ESRD Client Ø DM II q Ø Ø Ø ESRD…hemodialysis 3

Patho of One Dialysis/ESRD Client Ø DM II q Ø Ø Ø ESRD…hemodialysis 3 x/week Anemia CAD q q Ø Ø Ø PTCA 1994 w/redo 2005 AMI 2005 -stent to LAD, Cx CHF q Ø Retinopathy 25% EF w/global hypokinesis and severe inferior hypokinesis AFib AAA Neuropathy Obesity Rt Femoral Bypass Rt BKA Medications Ø ASA Ø Phoslo Ø Coumadin Ø Digoxin Ø Epoetin Ø Lantus insulin Ø Novolog per sliding scale Ø Lipitor Ø Neurontin Ø NTG subl prn 11

ED Renal Case Study 69 yr female Ø HPI: Hemodialysis earlier in day. Found

ED Renal Case Study 69 yr female Ø HPI: Hemodialysis earlier in day. Found to have HR in the 40’s afterwards. Did not increase. Has no c/o lightheadedness. Has no other physical c/o Ø VS: T-97. 8 P-42 (AFib) R-20 BP-122/76 sats 96% 3 l per n/c Ø 12

Labs 13

Labs 13

Excess Fluid Volume Ø Interventions: q Monitor I&O q Promote fluid balance ü Daily

Excess Fluid Volume Ø Interventions: q Monitor I&O q Promote fluid balance ü Daily weights ü 1 kg=1 liter fluid q Assess for manifestations of volume excess: ü Crackles in the bases of the lungs ü Edema ü Distended neck veins q Diuretics ü Contraindicated w/ESRD 14

Decreased Cardiac Output Ø Interventions: q Control hypertension ü calcium channel blockers ü ACE

Decreased Cardiac Output Ø Interventions: q Control hypertension ü calcium channel blockers ü ACE inhibitors ü alpha- and beta-adrenergic blockers ü vasodilators. q Education: monitor blood pressure ü client’s weight ü Diet ü Drug regimen ü 15

Potential for Pulmonary Edema Ø Interventions: q Assess for early signs of pulmonary edema

Potential for Pulmonary Edema Ø Interventions: q Assess for early signs of pulmonary edema ü Restlessness/anxiety ü Tachycardia ü Tachypnea ü oxygen saturation levels ü Crackles in bases q Hypertension 16

Imbalanced Nutrition Ø Interventions: q Dietary evaluation for: ü Protein ü Fluid ü Potassium

Imbalanced Nutrition Ø Interventions: q Dietary evaluation for: ü Protein ü Fluid ü Potassium ü Sodium ü Phosphorus q Vitamin supplementation ü Iron ü Water soluable vitamins ü Calcium ü Vitamin D 17

Risk for Infection Ø Interventions: q Meticulous skin care q Preventive skin care q

Risk for Infection Ø Interventions: q Meticulous skin care q Preventive skin care q Inspection of vascular access site for dialysis q Monitoring of vital signs for manifestations of infection 18

Risk for Injury Ø Interventions: q Drug therapy q Education prevent fall ü Injury

Risk for Injury Ø Interventions: q Drug therapy q Education prevent fall ü Injury ü pathologic fractures ü bleeding ü toxic effects of prescribed drugs ü – Digoxin – Narcotics – Heparin or Coumadin 19

Fatigue Ø Interventions: q Assess for vitamin deficiency ü Administer q vitamin and mineral

Fatigue Ø Interventions: q Assess for vitamin deficiency ü Administer q vitamin and mineral supplements anemia ü Give iron supplements as needed ü Erythropoietin therapy q Buildup of urea 20

Anxiety Ø Interventions: q Health care team involvement q Client and family education q

Anxiety Ø Interventions: q Health care team involvement q Client and family education q Continuity of care q Encouragement of client to ask questions and discuss fears about the diagnosis of renal failure 21

Indications for Dialysis Uremia Ø Persistent hyperkalemia Ø Uncompensated metabolic acidosis Ø Fluid volume

Indications for Dialysis Uremia Ø Persistent hyperkalemia Ø Uncompensated metabolic acidosis Ø Fluid volume excess unresponsive to diuretics Ø Uremic pericarditis Ø Uremic encephalopathy Ø 22

Hemodialysis Ø Client selection q Irreversible renal failure q Expectation for rehab q Acceptance

Hemodialysis Ø Client selection q Irreversible renal failure q Expectation for rehab q Acceptance of regimen Ø Dialysis settings q Acute-hospital q Out patient centers 23

Hemodialysis: Patho Ø Ø Diffusion Dialysate q Ø Ø Lytes and H 2 O

Hemodialysis: Patho Ø Ø Diffusion Dialysate q Ø Ø Lytes and H 2 O Dialyzer Anticoagulation q Heparin to prevent blood clots in dialyzer or tubing 24

Complications of Hemodialysis Dialysis disequilibrium syndrome Ø Infectious diseases Ø Hepatitis B and C

Complications of Hemodialysis Dialysis disequilibrium syndrome Ø Infectious diseases Ø Hepatitis B and C infections Ø HIV exposure—poses some risk for clients undergoing dialysis Ø 25

Vascular Access Ø Ø Ø Arteriovenous fistula, or arteriovenous graft for longterm permanent access

Vascular Access Ø Ø Ø Arteriovenous fistula, or arteriovenous graft for longterm permanent access Hemodialysis catheter, dual or triple lumen, or arteriovenous shunt for temporary access Precautions q q Ø Bruit & thrill BP restrictions Complications q q Thrombosis CMS 26

Hemodialysis: Nursing Interventions Ø Ø Predialysis care: q Medications to hold…why? Postdialysis care: q

Hemodialysis: Nursing Interventions Ø Ø Predialysis care: q Medications to hold…why? Postdialysis care: q Monitor for complications such as hypotension, headache, nausea, malaise, vomiting, dizziness, muscle cramps. q Monitor vital signs and weight. ü sepsis q Avoid invasive procedures 4 to 6 hours after dialysis. q Continually monitor for hemorrhage. q Assess for thrill q No BP or blood draws on arm 27

Peritoneal Dialysis 28

Peritoneal Dialysis 28

Peritoneal Dialysis Ø Phases q q q Ø Inflow Dwell Drain Contraindications q history

Peritoneal Dialysis Ø Phases q q q Ø Inflow Dwell Drain Contraindications q history of abd surgeries q recurrent hernias q excessive obesity q preexisting vertebral disease q severe obstructive pulmonary disease 29

Complications of Peritoneal Dialysis Ø Ø Ø Peritonitis (cloudy outflow) Pain Exit site and

Complications of Peritoneal Dialysis Ø Ø Ø Peritonitis (cloudy outflow) Pain Exit site and tunnel infections Poor dialysate flow Dialysate leakage Monitor color of outflow q cloudy (peritonitis) q brown (bowel) q bloody (first week OK) q urine (bladder) 30

Nursing Care During Peritoneal Dialysis Ø Ø Pre PD: q Vital signs pre and

Nursing Care During Peritoneal Dialysis Ø Ø Pre PD: q Vital signs pre and q 15 -30” during q Weight q laboratory tests Continually monitor the client for: q respiratory distress q pain q discomfort Monitor prescribed dwell time and initiate outflow Observe outflow amount & pattern of fluid 31

Education Priorities Pathophysiology and manifestations Ø Complications Ø When to call the doctor Ø

Education Priorities Pathophysiology and manifestations Ø Complications Ø When to call the doctor Ø Keep record of all labs Ø Take medications and follow plan of care set out by case manager Ø Monitor weight, fatigue levels closely Ø 32